Patent ID: 7465811

Claim:
A sulfonylindoline compound, selected from the group consisting of: i) compounds corresponding to formula (I) in which: R 1 is a hydrogen atom, a halogen, a C 1 -C 4 alkyl group, a C 1 -C 4 alkoxy group, a trifluoromethyl group or a totally or partially halogenated methoxy group, R 2 is a hydrogen atom, a halogen, a C 1 -C 4 alkyl group or a trifluoromethyl group, R 3 is a hydrogen atom, a halogen, a C 1 -C 4 alkyl group or a trifluoromethyl group, with the proviso that R 1 , R 2 and R 3 are not simultaneously a hydrogen atom, R 4 is a hydrogen atom or a C 1 -C 4 alkoxy group, Y is a linear or branched C 1 -C 8 alkylene group optionally substituted by a trifluoromethyl group or by a phenyl ring, or containing a cyclized part having 3 to 6 carbon atoms, or is a group —(CH 2 ) n —W—, W is an oxygen atom, a group —NH— or a sulfur atom, n is 2, 3 or 4, Z is an optionally partially halogenated C 1 -C 4 alkyl group, trifluoromethyl, —COR a , —CH 2 —N(R) 2 , or an aromatic, heteroaromatic or heterocyclic ring selected from phenyl, pyrrolidinyl, pyrrolidinylone, imidazolyl, pyridinyl, pyridinyl oxide, piperidinyl, piperazinyl, pyridazinyl, morpholinyl and indolinylone groups, and optionally substituted by one, two or three identical or different substituents selected from a halogen, a C 1 -C 4 alkyl group, C 1 -C 4 alkoxy, trifluoromethyl, nitro, N(R) 2 , —CH 2 —N(R) 2 , —O—(CH 2 ) n —N(R) 2 , hydroxyl, cyano, C 2 -C 3 cyanoalkyl, 5-oxo-1,2,4-oxadiazolidinyl and a group of the formula —X—[C(R) 2 ] p —COR a , X is a single bond, an oxygen atom, —O—CH 2 —, a sulfur atom, a group —NR— or a 1,1-cyclopropylene group, R a is OR or N(R) 2 , R is a hydrogen atom or a C 1 -C 4 alkyl group, and p is equal to 0, 1, 2, 3 or 4; and ii) the pharmaceutically acceptable salts of said compounds of formula (I).